Trademark search for:

RYZENDAK

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2017-05-09 — Application filed
2017-06-29 — Sn assigned for sect 66a subseq desig from ib
2017-06-30 — Application filed
2017-07-05 — Application filed
2017-07-07 — Assigned to examiner
2017-07-10 — Approved for pub - principal register
2017-07-11 — Application filed
2017-07-26 — Notice of publication
2017-08-15 — Published for opposition
2017-10-31 — Registered-principal register
2017-11-30 — Grant of protection created, to be sent to ib
2017-12-14 — Final disposition recorded
2017-12-14 — Final disposition recorded
2018-02-23 — Notification processed by ib
2020-11-17 — Final status recorded
2021-11-30 — Death of international registration
2021-11-30 — Notification of effect of cancellation of intl reg mailed

Owner Information

Novartis AG
CH

Correspondent

Novartis Pharma AG, Trademark Department
Postfach
CH-4002 Basel,
SWITZERLAND

Filing Details

Filing Date:
2017-05-09

Status Date:
2020-11-17

Category:
Pharmaceuticals

Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.